Kiniksa Pharmaceuticals International, plc number of employees

Kiniksa Pharmaceuticals International, plc reported 366 employees at December 31, 2025 in its latest annual report. Revenue per employee was $1.9m.

Headcount by year

Fiscal year end	Employees	Change	Revenue per employee	Source
December 31, 2025	366	—	$1.9m	10-K, filed February 24, 2026

What the annual reports say

As of December 31, 2025, we had 366 full-time employees, of which 351 were located within the United States and 15 were located outside of the United States. 2025 annual report

Headcount as the company states it in Item 1 of its annual report (some count full-time equivalents or exclude part-time and temporary staff), at the date it gives. Years where the report states no clear total are left out rather than estimated. Changes can reflect acquisitions and disposals as well as hiring and job cuts.

Compare with peers

Head to head: BBIO vs KNSA BCRX vs KNSA IONS vs KNSA

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Kiniksa Pharmaceuticals International, plc's SEC filings (10-K and 10-Q), retrieved October 31, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Kiniksa Pharmaceuticals International, plc.